Journal of Biosciences

, Volume 33, Issue 4, pp 505–514

Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India



Japanese encephalitis (JE) remains the most important cause of acute viral encephalitis and continues to spread to hitherto unaffected regions like Indonesia, Pakistan and Australia. Approximately 60% of the world population inhabits JE endemic areas. Despite its restricted range mostly in the developing countries, a high annual incidence of 50,000 cases and about 10,000 deaths has been reported. Disease can be fatal in 25% cases. Magnitude of the problem is even more alarming since the survivors are left with serious long-term neuropsychiatric sequelae. Almost every two years, epidemics of JE occur in Indian subcontinent with a high mortality. JE virus infection results in different disease manifestations in host from mild subclinical febrile illness to clinical infections leading to encephalitis. No antiviral treatment is so far available for JE. The prevention of JE can be achieved by controlling the vector or by immunization regime. The vector control in the rural areas, which are the worst affected ones, is practically almost impossible. Three vaccines that have been implicated against JE include inactivated mouse brain derived, inactivated cell culture derived and cell culture derived live attenuated JE vaccine. But each has its own limitation. Currently, attempts to synthesize recombinant DNA vaccine are being made. New therapeutics are on the way of development like use of minocycline, short interfering RNA, arctigenin, rosmarinic acid, DNAzymes etc. However, the immune mechanisms that lead to JE are complex and need to be elucidated further for the development of therapeutics as well as safe and efficacious JE vaccines.


Japanese encephalitis virus management prevention vaccine 

Abbreviations used


case fatality rate


granulocyte-macrophage colony-stimulating factor


Japanese encephalitis


JE virus


major histocompatibility complex




primary hamster kidney


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Appaiahgari M B and Vrati S 2004 Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells; Vaccine 22 3669–3675PubMedCrossRefGoogle Scholar
  2. Appaiahgari M B and Vrati S 2007 DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain; Mol. Ther. 15 1593–1599PubMedCrossRefGoogle Scholar
  3. Appaiahgari M B, Saini M, Rauthan M, Jyoti and Vrati S 2006 Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis; Microbes Infect. 8 92–104PubMedCrossRefGoogle Scholar
  4. Ashok M S and Rangarajan P N 1999 Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies; Vaccine 18 68–75PubMedCrossRefGoogle Scholar
  5. Bharati K and Vrati S 2006 Japanese encephalitis: Development of new candidate vaccines; Expert Rev. Anti Infect. Ther. 4 313–324PubMedCrossRefGoogle Scholar
  6. Bharati K, Appaiahgari M B and Vrati S 2005 Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice; Microbiol. Immunol. 49 349–353PubMedGoogle Scholar
  7. Burke D S and Morill J C 1987 Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis; J. Infect. Dis. 155 797–799PubMedGoogle Scholar
  8. Carey D E, Myers R M and Pavri K M 1968 Japanese encephalitis studies in Vellore, South India. II. Antibody response of patients; Indian J. Med. Res. 56 1319–1329PubMedGoogle Scholar
  9. Chakravarty S K, Sarkar J K, Chakravarty M S, Mukherjee M K, Mukherjee K K, Das B C and Hati A K 1975 The first epidemic of Japanese encephalitis studied in India—virologicalstudies; Indian J. Med. Res. 63 77–82PubMedGoogle Scholar
  10. Chang G J, Hunt A R and Davis B 2000 A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice; J. Virol. 74 4244–4252PubMedCrossRefGoogle Scholar
  11. Chaturvedi U C, Mathur A, Chandra A, Das S K, Tandon H O and Singh U K 1980 Transplacental infection with Japanese encephalitis virus; J. Infect. Dis. 141 712–715PubMedGoogle Scholar
  12. Chen C J, Raung S L, Kuo M D and Wang Y M 2002 Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs; J. Gen. Virol. 83 1897–1905PubMedGoogle Scholar
  13. Chen H W, Pan C H, Huan H W, Liau M Y, Chiang J R and Tao M H 2001 Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid; J. Immunol. 166 7419–7426PubMedGoogle Scholar
  14. Das B P, Lal S and Saxena V K 2004 Outdoor resting preference of Culex tritaeniorhynchus, the vector of Japanese encephalitis in Warangal and Karim Nagar districts, Andhra Pradesh; J. Vector Borne Dis. 41 32–36PubMedGoogle Scholar
  15. Gould E A, Zanotto P M and Holmes E C 1997 The genetic evolution of flaviviruses; in Factors in the emergence of arbovirus diseases (eds) J F Saluzzo and B Dodet (Paris: Elsevier) pp 51–63Google Scholar
  16. Grossberg S E and Scherer W F 1966 The effect of host age, viral dose and route of inoculation on inapparent infection in mice with Japanese encephalitis virus; Proc. Soc. Exp. Biol. Med. 123 118–124PubMedGoogle Scholar
  17. Guerin B and Pozzi N 2005. Viruses in boar semen: detection and clinical as well as epidemiological consequences regarding disease transmission by artificial insemination; Theriogenology 63 556–572PubMedCrossRefGoogle Scholar
  18. Guirakhoo F, Zhang Z X, Chambers T J, Delagrave S, Arroyo J, Barrett A D, Monath T P 1999 Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis; Virology 257 363–372PubMedCrossRefGoogle Scholar
  19. Gupta A K, Lad V J and Koshy A A 2003 Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies; Acta. Virol. 47 141–145PubMedGoogle Scholar
  20. Halstead S B and Jacobson J 2003 Japanese encephalitis; Adv. Virus Res. 61 103–138PubMedCrossRefGoogle Scholar
  21. Hanna J N, Ritchie S A, Phillips D A, Lee J M, Hills S L, van den Hurk A F, Pyke A T, Johansen C A and Mackenzie J S 1999 Japanese encephalitis in north Queensland, Australia, 1998; Med. J. Aust. 170 533–536PubMedGoogle Scholar
  22. Hanna J N, Ritchie S A, Phillips D A, Shield J, Bailey M C, Mackenzie J S, Poidinger M, McCall B J and Mills P J 1996 An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995; Med. J. Aust. 165 256–260PubMedGoogle Scholar
  23. Harinasuta C, Nimmanitya S and Titsyakorn U 1985 The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand; Southeast Asian J. Trop. Med. Public Health 16 332–336PubMedGoogle Scholar
  24. Harinasuta C, Wasi C and Vithanomsat S 1984 The effect of interferon on Japanese encephalitis virus in vitro; Southeast Asian J. Trop. Med. Public Health 15 564–568PubMedGoogle Scholar
  25. Hennessy S, Liu Z, Tsai T F, Strom B L, Wan C M, Liu H L, Wu T X, Yu H J, Liu Q M, Karabatsos N, Bilker W B and Halstead S B 1996 Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study; Lancet 347 1583–1586PubMedCrossRefGoogle Scholar
  26. Hoke C H, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis B L, Kotchasenee S, Gingrich J B, Latendresse J and Fukai K 1988 Protection against Japanese encephalitis by inactivated vaccines; N. Engl. J. Med. 319 608–614PubMedGoogle Scholar
  27. Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Ahmed A, Akram D S and Waqar M A 1994 Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan; Microbiol. Immunol. 38 827–830PubMedGoogle Scholar
  28. Innis B L 1995 Japanese encephalitis; in Exotic viral infections (ed.) J S Potterfield (London: Chapman and Hall) pp 147–174Google Scholar
  29. Kabilan L, Rajendran R, Arunachalam N, Ramesh S, Srinivasan S, Samuel P P and Dash A P 2004a Japanese encephalitis in India: an overview; Indian J. Pediatr. 71 609–615PubMedCrossRefGoogle Scholar
  30. Kanesa-Thasan N, Smucny J J, Hoke C H, Marks D H, Konishi E, Kurane I, Tang D B, Vaughn D W, Mason P W and Shope R E 2000 Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus—poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans; Vaccine 19 483–491PubMedCrossRefGoogle Scholar
  31. Kar N J, Bora D, Sharma R C, Bhattacharjee J, Datta K K and Sharma R S 1992 Epidemiological profile of Japanese encephalitis in Gorakhpur district, Uttar Pradesh, 1982–1988; J. Commun. Dis. 24 145–149PubMedGoogle Scholar
  32. Kaur R, Rauthan M and Vrati S 2004 Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein; Vaccine 22 2776–2782PubMedCrossRefGoogle Scholar
  33. Kaur R, Sachdeva G and Vrati S 2002 Plasmid DNA immunization against Japanese encephalitis virus: Immunogenecity of membrane-anchored and secretory envelope protein; J. Infect. Dis. 185 1–12PubMedCrossRefGoogle Scholar
  34. Kimura-Kiroda J and Yasui K 1988 Protection of mice against Japanese encephalitis virus by passive administration of monoclonal antibodies; J. Immunol. 141 3606–3610Google Scholar
  35. King N J, Getts D R, Getts M T, Rana S, Shrestha B and Kesson A M 2007 Immunopathology of flavivirus infections; Immunol. Cell Biol. 85 33–42PubMedCrossRefGoogle Scholar
  36. Konishi E, Ajiro N, Nukuzuma C, Mason P W and Kurane I 2003 Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice; Vaccine 21 3675–3683PubMedCrossRefGoogle Scholar
  37. Konishi E, Pincus S, Paoletti E, Shope R E and Wason P W 1994 Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens; Vaccine 12 633–638PubMedCrossRefGoogle Scholar
  38. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I and Mason P W 1998 Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes; J. Virol. 72 4925–4930PubMedGoogle Scholar
  39. Kumar P, Krishna V D, Sulochana P, Nirmala G, Haridattatreya M and Satchidanandam V. 2004b Cell-mediated immune res-ponses in healthy children with a history of subclinical infec-tion with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain; J. Gen. Virol. 85 471–482PubMedCrossRefGoogle Scholar
  40. Kumar P, Lee S K, Shankar P and Manjunath N 2006 A single siRNA suppresses fatal encephalitis induced by two different flaviviruses; PLoS Med. 3(4) e96 doi:10.1371/journal.pmed.0030096PubMedCrossRefGoogle Scholar
  41. Kumar P, Sulochana P, Nirmala G, Haridattatreya M and Satchidanandam V. 2004a. Conserved amino acids 193–324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort; J. Gen. Virol. 85 1131–1143PubMedCrossRefGoogle Scholar
  42. Kumar R, Mathur A, Kumar A, Sharma S, Chakraborty S and Chaturvedi U C 1990 Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India); Indian J. Med. Res. 91 321–327PubMedGoogle Scholar
  43. Liao C L, Lin Y L, Wu B C, Tsao C H, Wang M C, Liu C I, Huang Y L, Chen J H, Wang J P and Chen L K 2001 Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation; J. Virol. 75 7828–7839PubMedCrossRefGoogle Scholar
  44. Lin Y L, Chen L K, Liao C L, Yeh C T, Ma S H, Chen J L, Huang Y L, Chen S S and Chiang H Y 1998 DNA immunization with Japanese encephalitis virus non-structural protein NS-1 elicits protective immunity in mice; J. Virol. 72 191–200PubMedGoogle Scholar
  45. Mathur A, Arora K L and Chaturvedi U C 1981 Congenital infection of mice with Japanese encephalitis virus; Infect. Immun. 34 26–29PubMedGoogle Scholar
  46. Mathur A, Arora K L and Chaturvedi U C 1982 Transplacental Japanese encephalitis virus (JEV) infection in mice during consecutive pregnancies; J. Gen. Virol. 59 213–217PubMedCrossRefGoogle Scholar
  47. McCown J, Cochran M, Putnak R, Feighny R, Burrous J, Henchal E and Hoke C 1990 Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine; Am. J. Trop. Med. Hyg. 42 491–499PubMedGoogle Scholar
  48. Monath T P, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C and Bedford P 2003 Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen; J. Infect. Dis. 188 1213–1230PubMedCrossRefGoogle Scholar
  49. Monath T P, Soike K, Levenbook I, Zhang Z X, Arroyo J, Delagrave S, Myers G, Barrett A D, Shope R E, Ratterree M, Chambers T J and Guirakhoo F 1999 Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates; Vaccine 17 1869–1882PubMedCrossRefGoogle Scholar
  50. Namachivayam V and Umayal K 1982 Proceedings of National Conference on Japanese Encephalitis (New Delhi: Indian Council of Medical Research) pp 30–33Google Scholar
  51. Ni H, Burns N J, Chang G J, Zhang M J, Wills M R, Trent D W, Sanders P G and Barrett A D 1994 Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives; J. Gen. Virol. 75 1505–1510PubMedCrossRefGoogle Scholar
  52. Nukuzuma C, Ajiro N, Wheeler C J and Konishi E 2003 Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice; Viral Immunol. 16 183–189PubMedCrossRefGoogle Scholar
  53. Okamoto S, Yoshii H, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K and Mori Y 2008 Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus; Vaccine 26 589–594PubMedCrossRefGoogle Scholar
  54. Pan C H, Chen H W, Huang H W and Tao M H 2001 Protective mechanisms induced by a Japanese encephalitis virus vaccine: requirement for antibody but not CD8+ cytotoxic T cell responses; J. Virol. 75 11457–11463PubMedCrossRefGoogle Scholar
  55. Parida M, Dash P K, Tripathi N K, Ambuj, Sannarangaiah S, Saxena P, Agarwal S, Sahni A K, Singh S P, Rathi A K, Bhargava R, Abhyankar A, Verma S K, Rao P V and Shekhar K 2006 Japanese Encephalitis Outbreak, India, 2005; Emerg. Infect. Dis. 12 1427–1430PubMedGoogle Scholar
  56. Phukan A C, Borah P K and Mahanta J 2004 Japanese encephalitis in Assam, northeast India; Southeast Asian J. Trop. Med. Public Health. 35 618–622PubMedGoogle Scholar
  57. Plesner A M 2003 Allergic reactions to Japanese encephalitis vaccine; Immunol. Allergy Clin. North Am. 23 665–697PubMedCrossRefGoogle Scholar
  58. Rao J S, Misra S P, Patanayak S K, Rao T V, Das Gupta R K and Thapar B R 2000 Japanese Encephalitis epidemic in Anantapur district, Andhra Pradesh (October–November, 1999); J. Commun. Dis. 32 306–312PubMedGoogle Scholar
  59. Rathi A K, Kushwaha K P, Singh Y D, Singh J, Sirohi R, Singh R K and Singh U K 1993 JE virus encephalitis: 1988 epidemic at Gorakhpur; Indian Pediatr. 30 325–333PubMedGoogle Scholar
  60. Rauthan M, Kaur R, Appaiahgari M B and Vrati S 2004 Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces antiviral antibodies; Microbes Infect. 6 1305–1311PubMedCrossRefGoogle Scholar
  61. Reuben R and Gajanana A 1997 Japanese encephalitis in India; Indian J. Pediatr. 64 243–251PubMedCrossRefGoogle Scholar
  62. Rosen L 1986 The natural history of Japanese encephalitis virus; Annu. Rev. Microbiol. 40 395–414PubMedCrossRefGoogle Scholar
  63. Saini M and Vrati S 2003 High-level synthesis of Johnson grass mosaic virus coat protein in Escherichia coli and its autoassembly to form virus-like particles; Protein Exp. Purif. 28 86–92CrossRefGoogle Scholar
  64. Scherer W F, Kitaoka M, Okuno T and Ogata T 1959 Ecologic studies of Japanese encephalitis virus in Japan. VII. Human infection; Am. J. Trop. Med. Hyg. 8 707–715PubMedGoogle Scholar
  65. Seif S A, Morita K and Igarashi A 1996 A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice; Virus Res. 43 91–96PubMedCrossRefGoogle Scholar
  66. Seif S A, Morita K, Matsuo S, Hasebe F and Igarashi A 1995 Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system; Vaccine 13 1515–1521PubMedCrossRefGoogle Scholar
  67. Solomon T 1997 Viral encephalitis in Southeast Asia; Neurol. Infect. Epidemiol. 2 191–199Google Scholar
  68. Solomon T, Dung M N, Kneen R, Gainsborough M, Vaughn D W and Khanh V T 2000 Japanese Encephalitis; J. Neurol. Neurosurg. Psychiatry 68 405–415PubMedCrossRefGoogle Scholar
  69. Solomon T, Dung N M, Wills B, Kneen R, Gainsborough M, Diet T V, Thuy T T, Loan H T, Khanh V C, Vaughn D W, White N J and Farrar J J 2003 Interferon alfa-2a in Japanese encephalitis: a randomized double-blind placebo-controlled trial; Lancet. 361 821–826PubMedCrossRefGoogle Scholar
  70. Solomon T, Kneen R, Dung N M, Khanh V C, Thuy T T, Ha D Q, Day N P, Nisalak A, Vaughn D W and White N J 1998 Poliomyelitis-like illness due to Japanese encephalitis virus; Lancet 351 1094–1097PubMedCrossRefGoogle Scholar
  71. Srivastava A K, Putnak J R, Lee S H, Hong S P, Moon S B, Barvir D A, Zhao B, Olson R A, Kim S O, Yoo W D, Towle A C, Vaughn D W, Innis B L and Eckels K H. 2001 A purified inactivated Japanese encephalitis virus vaccine made in Vero cells; Vaccine 19 4557–4565PubMedCrossRefGoogle Scholar
  72. Swarup V, Ghosh J, Ghosh S, Saxena A and Basu A 2007 Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis; Antimicrob. Agents Chemother. 51 3367–3370PubMedCrossRefGoogle Scholar
  73. Swarup V, Ghosh J, Mishra M K and Basu A 2008 Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan; J. Antimicrob. Chemother. 61 679–688PubMedCrossRefGoogle Scholar
  74. Takegami T, Simamura E, Hirai K and Koyama J 1998 Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus; Antiviral Res. 37 37–45PubMedCrossRefGoogle Scholar
  75. Tiroumourougane S V, Raghava P and Srinivasan S 2002 Japanese viral encephalitis; Postgrad. Med. J. 78 205–215PubMedCrossRefGoogle Scholar
  76. Tsai T F, Chang G J and Yu X Y 1999 Japanese encephalitis vaccine. In: Plotkins SA, Orenstein ok, Thailand, 13–15 October 1998; Vaccine 18 1–25CrossRefGoogle Scholar
  77. Vajpayee A, Dey P N, Chakraborty A K and Chakraborty M S 1992 Study of the outbreak of Japanese encephalitis in Lakhimpur district of Assam in 1989; J. Indian Med. Assoc. 90 114–115PubMedGoogle Scholar
  78. Vaughn D W and Hoke Jr C H 1992 The epidemiology of Japanese encephalitis: Prospects for prevention; Epidemiol. Rev. 14 197–221PubMedGoogle Scholar
  79. Victor T J, Malathi M, Ravi V, Palani G and Appavoo N C 2000 First outbreak of Japanese encephalitis in two villages of Dharmapuri district in Tamil Nadu; Indian J. Med. Res. 112 193–197PubMedGoogle Scholar
  80. Vrati S 2000 Comparison of the genome sequences and the phylogenetic analyses of the GP78 and the Vellore P20778 isolates of Japanese encephalitis virus from India; J. Biosci. 25 257–262PubMedCrossRefGoogle Scholar
  81. Xin Y Y, Ming Z G, Peng G Y, Jian A and Min L H 1988 Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children; Am. J. Trop. Med. Hyg. 39 214–217PubMedGoogle Scholar
  82. Xin Y Y, Ming Z G, Peng G Y, Jian A and Min L H 1988 Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children; Am. J. Trop. Med. Hyg. 39 214–217PubMedGoogle Scholar
  83. Yang D K, Kweon C H, Kim B H, Lim S I, Kwon J H, Kim S H, Song J Y and Han H R 2005 Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice; J. Vet. Sci. 6 125–133PubMedGoogle Scholar
  84. Yang D K, Kweon C H, Kim B H, Lim S I, Kwon J H, Kim S H, Song J Y and Han H R 2005 Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice; J. Vet. Sci. 6 125–133PubMedGoogle Scholar
  85. Zhang M J, Wang M J, Jiang S Z and Ma W Y 1989 Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies; J. Med. Virol. 29 133–138PubMedCrossRefGoogle Scholar
  86. Zhang M J, Wang M J, Jiang S Z and Ma W Y 1989 Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies; J. Med. Virol. 29 133–138PubMedCrossRefGoogle Scholar
  87. Zimmerman M D, Scott R M, Vaughn D W, Rajbhandari S, Nisalak A and Shrestha M P 1997 Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal; Am. J. Trop. Med. Hyg. 57 283–284PubMedGoogle Scholar
  88. Zimmerman M D, Scott R M, Vaughn D W, Rajbhandari S, Nisalak A and Shrestha M P 1997 Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal; Am. J. Trop. Med. Hyg. 57 283–284PubMedGoogle Scholar

Copyright information

© Indian Academy of Sciences 2008

Authors and Affiliations

  1. 1.Department of MicrobiologySanjay Gandhi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations